Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This phase 3 is designed to test the effectiness of intranasal Oxytocin on Prader Willi
Syndrome (PWS).
This is a prospective, multicentre, randomised, double-blind, Phase 3 clinical study planned
to include around 36 PWS patients aged 2-17 years and 5 months.